Cargando…
How to Choose the Biologic Therapy in a Bio-naïve Patient with Inflammatory Bowel Disease
The availability of biologic therapies in inflammatory bowel disease (IBD) is increasing significantly. This represents more options to treat patients, but also more difficulties in choosing the therapies, especially in the context of bio-naïve patients. Most evidence of safety and efficacy came fro...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837085/ https://www.ncbi.nlm.nih.gov/pubmed/35160280 http://dx.doi.org/10.3390/jcm11030829 |